The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
